Multiplexed Solutions for Vaccine Testing
InDevR develops multiplexed analytical solutions that accelerate the development and manufacturing of vaccines and biotherapeutics. Its flagship VaxArray Platform delivers rapid, GMP-compliant multiplex immunoassay results for mRNA, polysaccharide, conjugate, and viral vector vaccines. In February 2026, the company was acquired by SSI Diagnostica Group, a global provider of infectious disease testing solutions.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2019
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
